Table 1.

Outcomes considered relevant for study inclusion

OUTCOME	WHAT THE OUTCOME INCLUDES
Morbidity and mortality	Mortality, fatal and nonfatal overdose, suicide, hospitalization or emergency department visits, and acquiring infections such as hepatitis B and C
Societal outcomes	Crime, incarceration, employment, housing, and transmission of infections such as hepatitis B and C
Quality of life and symptoms	Incidence of adverse events, withdrawal symptoms, patient satisfaction, quality-of-life scales, and scales related to guideline questions (eg, pain, anxiety)
Opioid use and treatment retention	Ongoing opioid use (from urine toxicology preferentially) and remaining in treatment